FDA issues Emergency Use Authorizations for two animal drugs to prevent and treat New World screwworm infestations in livestock, poultry, and exotic animals following HHS's August 18, 2025 public health emergency declaration.
Nasdaq GEMX amends its options regulatory fee structure effective immediately under self-regulatory organization rules.
Tell Bizmoon what your business does and we'll cut the Federal Register down to what actually matters.
Every rule is broken into specific to-dos with calendar dates.
We tell you which parts of your business each rule actually touches.
After healthcare come the capital-heavy sectors: trade, transportation, energy, and finance. If you operate in one of them, the volume of change is relentless.
NHTSA denied petition DP21-003 requesting investigation of alleged runaway throttle and speed control defects in Kia and Hyundai vehicles, finding insufficient evidence that accelerator systems violate Federal Motor Vehicle Safety Standards.
MARAD is soliciting comments on a request to operate the foreign-built vessel S/V Purple Pelican in U.S. coastwise trade carrying up to twelve passengers for hire to assess potential adverse effects on U.S. vessel builders and domestic maritime oper…
FAA announces charter renewal and membership nominations for the National Airspace System Advisory Committee, which advises on air traffic management systems and integration of new aviation technologies.
PHMSA seeks comments on revised incident, accident, and annual report forms for gas and hazardous liquid pipeline facilities plus the National Pipeline Mapping System under the Paperwork Reduction Act.
Long-Term Stock Exchange proposes amending rules to modify market maker requirements and obligations for listed securities on its exchange.
Nasdaq Texas amends its options regulatory fee structure under self-regulatory organization rules, effective immediately upon filing.
Nasdaq PHLX LLC amends its options regulatory fee structure under self-regulatory organization rules with immediate effectiveness.
FDA withdraws approval of SpecGx LLC's abbreviated new drug application for Methylphenidate Hydrochloride Extended-Release tablets in 27mg, 36mg, and 54mg strengths per the applicant's request.
No legal jargon. Read the impact in two sentences.
Email + dashboard pings the moment something changes.
